Advisers to the Nation on Science, Engineering, and Medicine

Nuclear and Radiation Studies Board

500 Fifth Street, NW Washington, DC 20001 Phone: 202 334 3066 Fax: 202 334 3077

July 23, 2008

Richard Cote


2251 Speakman Drive Mississauga, Ontario L5K 1B2

Dear Mr. Cote:

As a follow-up to my July 17 email message, I am sending along a list of questions (Attachment 1) from the Committee on Medical Isotope Production without Highly Enriched Uranium. This committee was appointed by the National Academies to carry out a U.S. Government-mandated study to assess the feasibility (including costs) of eliminating the use of highly enriched uranium (HEU) in medical isotope production; the impacts of HEU elimination on the reliability of medical isotope supply; and the progress being made by the Department of Energy and others to eliminate the use of HEU in research reactors, targets, and medical isotope production facilities. AECL’s responses to these questions will help ensure that the committee’s report to the U.S. Government is accurate and complete.

In connection with question 6 in the attachment, the committee requests that AECL provide a copy of its feasibility study on converting the Dedicated Isotope Facility to process low enriched uranium targets.

We recognize that some of the information we have requested may be business sensitive. The National Academies are willing to execute a non-disclosure agreement with AECL to facilitate access to this information. If desired by AECL, I can also arrange for a small group of committee and staff to visit your facility to review the feasibility study and discuss the questions in the attachment.

Please feel free to call me if you have questions or need additional information about this request or our study.


Kevin Crowley

Study Director

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement